Prognostic value of test(s) for O(6)‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide

This is a protocol for a Cochrane Review (Prognosis). The objectives are as follows: Primary objective The primary objective of this review is to determine which technique (test) for assessing MGMT methylation status best predicts overall survival in people diagnosed with glioblastoma who are treate...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: McAleenan, Alexandra, Howell, Amy, Kernohan, Ashleigh, Faulkner, Claire L, Dawson, Sarah, Wragg, Christopher, Jefferies, Sarah, Brandner, Sebastian, Vale, Luke, Higgins, Julian P T, Kurian, Kathreena M
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2019
Témata:
Medicine General & Introductory Medical Sciences
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489695/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013316
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky